Product: | Darunavir-d9 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | D8750 | ||||||||
Unlabeled CAS Number: | 206361-99-1 | ||||||||
Synonyms: |
[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl-d9)amino]-2-hydroxy-1-(phenyl-methyl)propyl]carabamic Acid (3R,3aS,6aR)-Hexahydrofuro[2,3-β]-furan-3-yl Ester; TMC-114-d9; UIC-94017-d9 |
||||||||
Pricing: |
|
||||||||
Formula: | C27H28D9N3O7S | ||||||||
Enrichment: | 99%D | ||||||||
Chemical Purity: | 98% | ||||||||
Molecular Weight: | 556.72 | ||||||||
Structure: | |||||||||
Appearance: | White solid | ||||||||
Category: | Research Compounds | ||||||||
Stability: | Stable under recommended storage conditions | ||||||||
Storage: |
Keep container tightly closed in a dry and well-ventilated place. Store at -20°C under inert atmosphere |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
Koh, Y., et al.: Antimicrob. Agents Chemother., 47, 3123 (2003), Arasteh, K., et al.: AIDS, 19, 943 (2005), Surleraux, D.L.N.G., et al.: J. Med. Chem., 48, 1813 (2005), |
||||||||
MSDS: | |||||||||
Description: |
Second generation HIV-1-protease inhibitor; structurally similar to amprenavir. Antiviral |